✦ LIBER ✦

Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases

✍ Scribed by K. Kerl; C. Prins; J.H. Saurat; L.E. French

Book ID: 108669076
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 267 KB
Volume: 155
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2006.07523.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intralesional therapy with anti-CD20 mon

Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma

✍ A.M. Roguedas; H. Watier; G. Paintaud; A. De Muret; L. Vaillant; L. Machet 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

Successful treatment and re-treatment of

Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab

✍ M. Herold; A. Schulze; K. Härtwig; G. Anger 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 46 KB

Treatment of radiation-relapsing primary

Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody

✍ M. E. Lacouture; J. M. Baron; A. B Jani; A. E Laumann; K Soltani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Experimental treatment of human diffuse

Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab

✍ Franck Assayag; Nicole Brousse; Jérôme Couturier; Elizabeth Macintyre; Claire Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

Reduction of tumor burden and stabilizat

Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma

✍ Lucie M. Heinzerling; Margarete Urbanek; Jens O. Funk; Stefan Peker; Oliver Blec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Successful treatment of thrombocytopenia

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case report

✍ R. Trappe; A. Loew; P. Thuss-Patience; B. Dörken; H. Riess 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 87 KB